Northern Trust’s Cidara Therapeutics CDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.07M Buy
145,171
+111,611
+333% +$5.44M ﹤0.01% 2264
2025
Q1
$723K Sell
33,560
-397
-1% -$8.55K ﹤0.01% 3415
2024
Q4
$913K Buy
33,957
+2,170
+7% +$58.3K ﹤0.01% 3434
2024
Q3
$342K Buy
+31,787
New +$342K ﹤0.01% 3695
2024
Q2
Sell
-8,018
Closed -$148K 4425
2024
Q1
$148K Sell
8,018
-11
-0.1% -$202 ﹤0.01% 3978
2023
Q4
$127K Buy
8,029
+1,631
+25% +$25.9K ﹤0.01% 4049
2023
Q3
$121K Hold
6,398
﹤0.01% 3962
2023
Q2
$145K Buy
6,398
+801
+14% +$18.1K ﹤0.01% 3938
2023
Q1
$142K Buy
5,597
+322
+6% +$8.18K ﹤0.01% 3977
2022
Q4
$79.8K Hold
5,275
﹤0.01% 4167
2022
Q3
$66K Buy
5,275
+355
+7% +$4.44K ﹤0.01% 4244
2022
Q2
$48K Hold
4,920
﹤0.01% 4420
2022
Q1
$82K Sell
4,920
-605
-11% -$10.1K ﹤0.01% 4407
2021
Q4
$140K Buy
5,525
+2,039
+58% +$51.7K ﹤0.01% 4317
2021
Q3
$156K Sell
3,486
-135
-4% -$6.04K ﹤0.01% 4266
2021
Q2
$146K Sell
3,621
-15,099
-81% -$609K ﹤0.01% 4258
2021
Q1
$996K Sell
18,720
-781
-4% -$41.6K ﹤0.01% 3587
2020
Q4
$780K Buy
19,501
+254
+1% +$10.2K ﹤0.01% 3602
2020
Q3
$1.1M Buy
19,247
+13,346
+226% +$761K ﹤0.01% 3359
2020
Q2
$436K Buy
5,901
+3,480
+144% +$257K ﹤0.01% 3590
2020
Q1
$120K Buy
2,421
+959
+66% +$47.5K ﹤0.01% 3783
2019
Q4
$112K Buy
1,462
+207
+16% +$15.9K ﹤0.01% 3914
2019
Q3
$50K Sell
1,255
-47
-4% -$1.87K ﹤0.01% 4048
2019
Q2
$44K Sell
1,302
-179
-12% -$6.05K ﹤0.01% 4098
2019
Q1
$79K Sell
1,481
-688
-32% -$36.7K ﹤0.01% 3969
2018
Q4
$102K Buy
2,169
+13
+0.6% +$611 ﹤0.01% 3918
2018
Q3
$190K Buy
2,156
+287
+15% +$25.3K ﹤0.01% 3880
2018
Q2
$195K Buy
1,869
+90
+5% +$9.39K ﹤0.01% 3866
2018
Q1
$142K Buy
1,779
+901
+103% +$71.9K ﹤0.01% 3890
2017
Q4
$119K Sell
878
-29
-3% -$3.93K ﹤0.01% 3937
2017
Q3
$147K Sell
907
-1
-0.1% -$162 ﹤0.01% 3865
2017
Q2
$137K Sell
908
-4,719
-84% -$712K ﹤0.01% 3902
2017
Q1
$878K Buy
5,627
+331
+6% +$51.6K ﹤0.01% 3389
2016
Q4
$1.1M Buy
5,296
+508
+11% +$106K ﹤0.01% 3323
2016
Q3
$1.1M Sell
4,788
-9
-0.2% -$2.06K ﹤0.01% 3319
2016
Q2
$989K Buy
4,797
+2,286
+91% +$471K ﹤0.01% 3350
2016
Q1
$638K Buy
2,511
+4
+0.2% +$1.02K ﹤0.01% 3396
2015
Q4
$860K Buy
2,507
+156
+7% +$53.5K ﹤0.01% 3369
2015
Q3
$599K Buy
+2,351
New +$599K ﹤0.01% 3452